L. Daly

University of the Pacific — United States

Medicine · Health Sciences

14h-index908citations30works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(9), Monoclonal and Polyclonal Antibodies Research(4), Reproductive System and Pregnancy(4), Glycosylation and Glycoproteins Research(3), HER2/EGFR in Cancer Research(3)

Publications29 total

Uncommon Presentation of a Residual Cyst
Journal of the California Dental Association·2024Open Access
P207 Senolytic effects of Telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells
2023Open Access
CONFERENCE REPORT: Politics, Policies and Diplomacy of Diaspora Governance: New Directions in Theory and Research
MIGRATION LETTERS·2019Open Access
The Future of Standards for Digital Publishing
Data Archiving and Networked Services (DANS)·2014Open Access
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease
Respiratory Medicine COPD Update·2006· 20 cited
Coexpression of the HER-2 Gene Product, pl85 <sup>HER-2</sup> , and Epidermal Growth Factor Receptor, pl70 <sup>EGF-R</sup> , on Epithelial Ovarian Cancers and Normal Tissues
Hybridoma·1998· 37 cited
OVX1 and CEA in Patients with Colon Carcinoma, Colon Polyps and Benign Colon Disorders
The International Journal of Biological Markers·1998· 5 cited
Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer.
PubMed·1998· 25 cited
Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses
Gynecologic Oncology·1995· 104 cited
Complementary and coordinate markers for detection of epithelial ovarian cancers
1995· 5 cited
Breast cancer screening. Interpreting new data for clinical practice.
PubMed·1994
OVX1 as a marker for early stage endometrial carcinoma
Cancer·1994· 12 cited
Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
JNCI Journal of the National Cancer Institute·1993· 195 cited
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
Journal of Clinical Oncology·1993· 46 cited
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
International Journal of Gynecology & Obstetrics·1992
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
Journal of Clinical Oncology·1992· 14 cited
Ha-ras polymorphisms in epithelial ovarian cancer
Gynecologic Oncology·1992· 4 cited
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
American Journal of Obstetrics and Gynecology·1991· 78 cited
Coordinate elevation of serum markers in ovarian cancer but not in benign disease
Cancer·1991· 59 cited
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
American Journal of Obstetrics and Gynecology·1991· 57 cited
page 1 of 2Next →

Frequent Co-authors

Robert C. Bast(14), John T. Soper(12), Daniel L. Clarke‐Pearson(9), Andrew Berchuck(8), Kathy O'Briant(5), Feng Xu(4), Robert Woolas(3), David Oram(3), Verda J. Hunter(3), M. Tanner(3), Lisa Anselmino(3), Yanhong Yu(2), Fengji Xu(2), Ian Jacobs(2), Subramanian Ramakrishnan(2), Fred Tyson(2), C. Boyer(2), G P Cram(2), Wesley C. Fowler(2), William T. Creasman(2)